skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

Invasive Mycoses

(Last updated: September 1, 2014; last reviewed: September 1, 2014)

Invasive Mycoses
Member Financial Disclosure
Company Relationship
Ampel, Neil* University of Arizona Nielsen BioSciences Research Support
Blair, Janis Mayo Clinic Arizona None N/A
Hage, Chadi Indiana University None N/A
Hamill, Richard Baylor College of Medicine None N/A
Kauffman, Carol University of Michigan and VA Ann Arbor Healthcare System None N/A
Pappas, Peter University of Alabama at Birmingham Astellas Advisory Board, Consulting, Honoraria, Research Support
Merck Advisory Board, Research Support, Speaker’s Bureau
Pfizer Advisory Board, Research Support
T-2 Diagnostics Advisory Board
Perfect, John Duke University Amplyx Consultant, Research Support
Astellas
Advisory Board, Consultant, Honoraria, Research Support
Cidara Consultant
F2G Consultant
Merck Advisory Board, Consultant, Honoraria, Research Support
Minnetronix Consultant, Research Support
Pfizer Consultant, Honoraria, Research Support
Scynexis Consultant
TEVA Honoraria
Viamet Consultant
Vical Consultant

* Group lead

Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from November 1, 2014, through November 1, 2016.

Back to Top